NCT06333132View on ClinicalTrials.gov

Deciphering the Role of Incretin Hormones in Weight Loss-induced Remission of Type 2 Diabetes (DIABeat)

NANot yet recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

September 1, 2025

Study Completion Date

February 1, 2026

Conditions
ObesityDiabetes Mellitus Type 2 in Obese
Interventions
BEHAVIORAL

Weight loss-induced Diabetes Remission

Patients will undergo a dietary intervention plus drugs (if needed) with the purpose to obtain a 10% (or at least 10 kg) body weight reduction to achieve diabetes remission

Trial Locations (1)

56127

Azienda Ospedaliero-Universitaria Pisana, Pisa

All Listed Sponsors
lead

Azienda Ospedaliero, Universitaria Pisana

OTHER